Fig. 1From: Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TRRepresentative images of multiplex fluorescent immunohistochemistry. Multiplex fluorescent immunohistochemistry was performed using antibodies against CD3 (blue), CD4 (yellow), CD8 (red), Foxp3 (pink), CD204 (green), and pan-cytokeratin (brown)Back to article page